Janus Henderson Group Ltd.

13D and 13G Filings

Issuer % of Class Filed
Mereo Biopharma Group PLC 13G/A Amendment 2
MREO · 589492107
10.3% 12/6/2024
Event 11/29/2024
Applied Therapeutics, Inc. 13G/A Amendment 2
APLT · 03828A101
10.4% 12/6/2024
Event 11/29/2024
Ardelyx Inc 13G/A Amendment 4
ARDX · 039697107
10.1% 12/6/2024
Event 11/29/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.